Importation Of Italian-authorized Bupisen Iperbarica 7,5 Mg/ml Soluzione Iniettabile (bupivacaine Hydrochloride In Dextrose Injection) Due To The Current Shortage Of Canadian-authorized Bupivacaine Hy
Recall Summary Health Canada is recalling BUPISEN iperbarica 7.5 mg/ml injection (a local anesthetic containing bupivacaine) that was imported from Italy due to concerns about product safety, supply issues, and labelling. The product was distributed across Canada. This recall was issued because of a shortage of Canadian-authorized bupivacaine products.
- Product
- BUPISEN iperbarica 7,5 mg/ml soluzione iniettabile
- Reason
- Product safety - Supply - Labelling
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2026-11-19
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/b2acaf3d-700a-4e0d-a9f9-6533e32c86cd